ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.137,86
-0,44%
S&P 500
5.473,23
0,77%
US Dollar vs BRL
5,4252
1,40%
Bitcoin
66.642,98
0,00%
Brent Oil
83,90
2,16%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Wave Life Sciences Ltd (WVE)

  7. Wave Life Sciences Ltd (WVE) Notícias

WVE

Wave Life Sciences (WVE)

Wave Life Sciences Ltd
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:WVE
DataHoraFonteTítuloCódigoCompanhia
12/06/202409:30GlobeNewswire Inc.Wave Life Sciences Announces Upcoming Presentations Highlighting Novel siRNA Program in Obesity and Leadership in RNA EditingNASDAQ:WVEWave Life Sciences Ltd
30/05/202409:30GlobeNewswire Inc.Wave Life Sciences to Present at 2024 Jefferies Global Healthcare ConferenceNASDAQ:WVEWave Life Sciences Ltd
10/05/202408:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:WVEWave Life Sciences Ltd
09/05/202408:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:WVEWave Life Sciences Ltd
09/05/202408:30GlobeNewswire Inc.Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:WVEWave Life Sciences Ltd
09/05/202408:00GlobeNewswire Inc.Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific OfficerNASDAQ:WVEWave Life Sciences Ltd
07/05/202409:30GlobeNewswire Inc.Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:WVEWave Life Sciences Ltd
02/05/202409:30GlobeNewswire Inc.Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024NASDAQ:WVEWave Life Sciences Ltd
30/04/202409:30GlobeNewswire Inc.Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)NASDAQ:WVEWave Life Sciences Ltd
23/04/202409:30GlobeNewswire Inc.Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA EditingNASDAQ:WVEWave Life Sciences Ltd
27/03/202409:30GlobeNewswire Inc.Wave Life Sciences to Present at Upcoming Investor ConferencesNASDAQ:WVEWave Life Sciences Ltd
06/03/202409:55Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:WVEWave Life Sciences Ltd
06/03/202409:30GlobeNewswire Inc.Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:WVEWave Life Sciences Ltd
28/02/202410:30GlobeNewswire Inc.Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024NASDAQ:WVEWave Life Sciences Ltd
27/02/202410:30GlobeNewswire Inc.Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular DystrophyNASDAQ:WVEWave Life Sciences Ltd
12/02/202418:15Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:WVEWave Life Sciences Ltd
07/02/202421:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:WVEWave Life Sciences Ltd
08/01/202410:00GlobeNewswire Inc.Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 MilestonesNASDAQ:WVEWave Life Sciences Ltd
03/01/202410:30GlobeNewswire Inc.Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:WVEWave Life Sciences Ltd
15/12/202310:30GlobeNewswire Inc.Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular DystrophyNASDAQ:WVEWave Life Sciences Ltd
08/12/202308:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:WVEWave Life Sciences Ltd
07/12/202309:00GlobeNewswire Inc.Wave Life Sciences Prices $100 Million Public Offering of Ordinary SharesNASDAQ:WVEWave Life Sciences Ltd
06/12/202318:10GlobeNewswire Inc.Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded WarrantsNASDAQ:WVEWave Life Sciences Ltd
06/12/202318:08GlobeNewswire Inc.Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA Editing Candidate, WVE-006, for Alpha-1 Antitrypsin DeficiencyNASDAQ:WVEWave Life Sciences Ltd
22/11/202310:30GlobeNewswire Inc.Wave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI HealthCONx ConferenceNASDAQ:WVEWave Life Sciences Ltd
09/11/202310:52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:WVEWave Life Sciences Ltd
09/11/202309:30GlobeNewswire Inc.Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:WVEWave Life Sciences Ltd
03/11/202317:05GlobeNewswire Inc.Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023NASDAQ:WVEWave Life Sciences Ltd
28/09/202317:15GlobeNewswire Inc.Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D DayNASDAQ:WVEWave Life Sciences Ltd
25/09/202309:30GlobeNewswire Inc.Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines ConferenceNASDAQ:WVEWave Life Sciences Ltd
 Apresentando as notícias mais relevantes sobre:NASDAQ:WVE

Seu Histórico Recente

NASDAQ
AAYIJXX
Morgan Stanley Finance L...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados